-
Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims Data
12 Jan 2023 04:31 GMT
… adults.3 Lung cancer is a heterogenous disease. Most lung cancers in the … (incident) small-cell lung cancer (SCLC) and other lung cancers, a 5% random … , doxorubicin, irinotecan, vincristine, or topotecan]) for identifying NSCLC.
Statistical Analysis …
-
Immutep Quarterly Activities Report
30 Jan 2023 13:00 GMT
… 1st line non-small cell lung cancer (1L NSCLC)
Compelling Phase II … which is oxaliplatin, carboplatin, or topotecan. They follow the grant of …
-
Episode 5: Small Cell Lung Cancer Treatment Options
15 Nov 2022 14:43 GMT
… platinum-based therapy and topotecan in particular. What … these different small cell lung cancers. They look different … small cell lung cancer, we subtype small cell lung cancer into … Cell Lung Cancer
Testing Maintenance Therapy for Small Cell Lung Cancer …
-
G1 Therapeutics Announces Investigator Initiated Study of Trilaciclib and Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
26 Oct 2022 13:26 GMT
… in the context of topotecan-containing and platinum… with extensive stage small cell lung cancer (ES-SCLC). Secondary … lung cancer, accounts for about 10% to 15% of all lung cancers. … extensive stage small cell lung cancer. Forward-looking statements are …
-
Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year After Standard Treatment
17 Oct 2022 21:28 GMT
… lung cancer (NSCLC) accounts for approximately 80% of lung cancer cases. About 30% of lung cancer … patients are locally advanced lung cancer … cell lung cancer. Transl Lung Cancer Res … irinotecan versus topotecan alone …
-
Merrimack Provides Ipsen Report of Results From Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer
03 Aug 2022 14:17 GMT
… of second line small cell lung cancer (SCLC). The press release indicates … patients treated with Onivyde versus topotecan. However, a doubling of the …
-
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer
03 Aug 2022 05:22 GMT
… liposomal injection) versus topotecan in patients with small cell lung cancer (SCLC), who … injection) versus topotecan in patients with small cell lung cancer who have progressed … Cancer Quality of Life Questionnaire Lung Cancer 13 (EORTC QLQ-LC13) cough …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises an … Topotecan: an evolving option in the treatment of relapsed small cell lung cancer … or refractory small cell lung cancer. Lung Cancer. 2013;79(2): … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108–112 …
-
PharmaMar and Jazz Pharmaceuticals Announce Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca® (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell Lung Cancer'
13 Dec 2021 08:16 GMT
… patients with relapsed small cell lung cancer (SCLC). The trial … 's choice of topotecan or irinotecan, in patients … for the metastatic small cell lung cancer community,' said … extensive-stage small cell lung cancer.
Important Safety Information for …
-
Algernon Pharma initiates Ifenprodil small cell lung cancer research programme
12 Aug 2021 06:21 GMT
… (Ifenprodil) small cell lung cancer (SCLC) research programme … approximately 15% of all lung cancer cases.
In a … , entitled “Small-Cell Lung Cancer Growth Inhibition: Synergism Between … combination with chemotherapeutic agent topotecan, produced clear additive …
About
© 1995-2023